查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1190566

皮肤科设备市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Dermatology Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

皮肤科设备市场预计在预测期内（2022 年至 2027 年）将以 12.3% 的复合年增长率增长。

COVID-19 大流行的爆发对皮肤病设备市场产生了重大影响。 非必要业务的关闭扰乱了皮肤科行业。 Hamilton Fraser Cosmetic Insurance 于 2020 年 3 月对 1,360 名英国美容从业者进行调查，以评估大流行对其美容实践的影响，发现 99.78% 的从业者受到大流行的影响。据称，他透露自己受到了手术的影响当时。 因此，虽然 COVID-19 在大流行期间对市场增长率产生了重大影响，但由于全球封锁升级和美容治疗的恢復，预计市场将随着时间的推移而增长。

老年人口的增加、美容医学意识的增强以及皮肤医疗设备的技术进步等因素预计将推动市场增长。

世界各地越来越多的整容手术也产生了对皮肤科设备的需求，从而促进了市场的增长。 例如，根据国际整形与重建外科学会2021年12月发布的报告，2020年全球进行的整容/整容手术总数为1,624,281例，抽脂术（1,525,197例）、双眼皮手术（1,225,540例）、隆鼻术(852,554) 和腹部整形术 (765,248)。 此外，技术先进产品的推出也推动了市场增长。 例如，2021年12月，科学护肤公司、专业护肤产品领导者之一的Obagi推出了Skintrinsiq设备，标誌着其进军辅助护肤设备市场。 Obagi 是最早设计和开发专业面部设备的专业护肤公司之一，为 Obagi 的创新产品提供先进的输送系统。

此外，市场参与者的战略举措和产品批准也在推动市场增长。 例如，2022 年 6 月，卡西欧计算机完成了欧洲医疗器械法规 (MDR) 合规性研究，并为其 DZ-D100 皮肤病相机和 DZ-S50 皮肤病镜发布了欧盟合规性声明。 此外，“DZ-D100”和“DZ-S50”计划于2022年8月在欧洲发售，由卡西欧欧洲（德国诺德施泰特）和卡西欧电子（英国温布利）销售。据悉预定。 预计这些努力将对市场增长产生积极影响。

通过这些努力，该市场有望在未来实现显着增长。 然而，与皮肤病治疗相关的副作用和有关医疗器械的严格监管政策可能会阻碍分析期间的市场增长。

主要市场趋势

预计抗皱领域在预测期内将呈现高增长

由于老年人和老年人口的负担不断增加，以及随着产品的推出和批准，人们对整容手术的认识不断提高，预计抗皱领域在预测期内将出现显着增长。

人口老龄化也在推动这一细分市场的增长。 例如，根据加拿大统计局的 2021 年人口普查，2021 年加拿大 65 岁及以上人口大约有 7,021,430 人，其中男性 3,224,680 人，女性 3,796,750 人。 老龄化和老年人口的增加最终将导致面部老化并引起皱纹，这将增加对这些设备的需求。

此外，国家推出基于先进技术的除皱设备也有助于该细分市场的增长。 例如，2022 年 1 月，Lumenis 在英国市场推出了 Splendor X 设备。 该设备已通过 CE 认证，可用于治疗脱髮、血管治疗、色素病变和皱纹。 该仪器配备了 BLEND X 技术，可发射波长同步的 Nd:YAG（1064 nm）和紫翠玉（755 nm）比例可控的二元激光。 预计此类发布将推动该细分市场的增长。 此外，2021 年 4 月，Crown Laboratories 的一个部门 Crown Esthetics 获得了美国食品和药物管理局 (FDA) 的 SkinPen Precision 治疗颈部皱纹的许可。 预计此类批准也将促进市场的增长。

由于上述原因，市场有望在预测期内增长。

北美在皮肤科设备市场占有最大份额

北美占所研究市场的主要份额。 再加上皮肤癌、湿疹和红斑痤疮等皮肤病患病率上升，皮肤科设备获得批准，以及人们对整容手术的认识不断提高，这种趋势可能会持续下去。

根据美国癌症协会 2022 年的统计数据，美国预计将在 2022 年报告 99,780 例皮肤黑色素瘤新病例。 其中，登记了 57,180 例男性病例和 42,600 例女性病例。 因此，皮肤癌和其他皮肤病负担的增加极大地促进了对皮肤病设备的需求增加，从而促进了市场的增长。

此外，一些医疗技术公司正在专注于使患者护理更便宜、更快捷、更高效的产品。 例如，2020 年 7 月，Lancer Skin Care 推出了 Pro Polish 微晶换肤仪。 Propolish 通过在获得专利的手持设备中提供浅表微晶换肤术，提高了 Lancer 常规的有效性。 皮肤科设备的这种功能进步及其在皮肤病中的广泛应用预计将加强该地区对皮肤科设备的需求。 此外，2020 年 6 月，AbbVie（Allergan Esthetics）获得美国食品和药物管理局批准，将 JUVEDERM VOLUMA XC 作为一种颌骨增强手术，用于改善 21 岁及以上成年人的颌骨轮廓。知道了。 此类批准也在推动市场增长。

因此，由于上述因素，预计北美市场在预测期内将出现可观的增长。

竞争格局

皮肤科设备市场的竞争很低。 市场参与者正在通过不断创新市场上已有的设备来改进现有产品组合，从而扩展他们的皮肤病设备组合。 它还采取了增长战略，例如扩大产品线、地域扩张和扩大客户群。 主要参与者包括 Cutera Inc.、Hologic Inc.（Cynosure Inc.）、Lumenis Ltd.、Alma Lasers 和 Candela Corporation。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 皮肤病发病率增加
    • 皮肤护理设备的技术进步
    • 对整容手术的认识不断提高
  • 市场製约因素
    • 与皮肤病治疗相关的副作用
    • 严格的医疗器械监管政策
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按诊断设备类型
    • 成像设备
    • 皮肤镜
    • 显微镜
  • 通过使用诊断设备
    • 皮肤癌的诊断
    • 其他诊断设备应用
  • 按治疗设备类型
    • 光疗设备
    • 激光
    • 电外科单元
    • 吸脂器
    • 微晶换肤术
    • 冷冻治疗设备
  • 通过使用治疗设备
    • 血管病变
    • 痤疮、牛皮癣、去除纹身
    • 脱毛
    • 除皱
    • 塑身和去除脂肪
    • 其他治疗设备应用
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Abbvie Inc.（Allergan Inc.）
    • Alma Lasers Ltd
    • Bausch Health Companies Inc.（Solta Medical Inc.）
    • BrUnited Kingdomer Corporation
    • CANDELA CORPORATION
    • Carl Zeiss
    • Cutera Inc.
    • Galderma SA
    • Genesis Biosystems Inc.
    • Hologic Inc.（Cynosure Inc.）
    • Lumenis Ltd
    • Merz Pharma GmbH & Co. KGaA

第7章 市场机会今后动向

简介目录
Product Code: 64170

The Dermatology Devices Market is expected to register a CAGR of 12.3% during the forecast period (2022-2027).

The outbreak of the COVID-19 pandemic significantly impacted the dermatology devices market. The closure of non-essential businesses disrupted the dermatology industry. According to a survey by Hamilton Fraser Cosmetic Insurance, conducted in March 2020 with 1,360 cosmetic practitioners in United Kingdom to assess the impact of the pandemic on cosmetic procedures, stated that 99.78% of practitioners revealed that their practice was affected during the current pandemic. Thus, COVID-19 significantly impacted the growth rate of the market over the pandemic phase, although, with the upliftment of the lockdowns and the resumption of cosmetic treatments globally, the market is expected to show growth over time.

Factors such as the growing geriatric population, increasing awareness about aesthetic procedures, and technological advancements in dermatology devices are expected to propel the growth of the market.

The growing number of aesthetic procedures performed across the world also creates the need for dermatological devices and hence drives the growth of the market. For instance, according to the International Society of Plastic Surgeons report released in December 2021, the total number of aesthetic/cosmetic procedures performed in the year 2020 worldwide for breast augmentation were 1,624,281, liposuction (1,525,197), eyelid surgery (1,225,540), rhinoplasty (852,554), and abdominoplasty (765,248). Furthermore, the launch of technologically advanced products is also propelling the growth of the market. For instance, in December 2021, Obagi, a science-based skincare company and one of the leaders in professional skincare products, launched the Skintrinsiq device and made its entry into the complementary skincare device market. Obagi is one of the first professional skincare companies to design and develop a professional-use facial device offering an advanced delivery system for Obagi's transformational products.

Additionally, the strategic initiatives taken by the market players and approvals for the products are also boosting the growth of the market. For instance, in June 2022, Casio Computer Co., Ltd. issued an EU Declaration of Conformity regarding the DZ-D100 dermatology camera and DZ-S50 dermatology scope after the completion of conformity studies for European Medical Device Regulations (MDR). It also reported that the DZ-D100 and DZ-S50 are expected to launch in Europe in August 2022 and are scheduled to be sold by Casio Europe GmbH (Norderstedt, Germany) and Casio Electronics Co. Ltd. (Wembley, United Kingdom). Such initiatives are expected to have a positive impact on the growth of the market.

Thus, owing to the abovementioned factors, the market is expected to have significant growth over the forecast period. However, the side effects related to dermatological treatments and stringent regulatory policies for medical devices may hamper the growth of the market over the analysis period.

Key Market Trends

Wrinkle Removal Segment is Anticipated to Show High Growth Over the Forecast Period

The wrinkle removal segment is expected to project significant growth over the forecast period owing to factors such as the growing burden of the elderly and geriatric population, and increasing awareness about aesthetic procedures coupled with the launch and approval of the products.

The growing geriatric population is also boosting the growth of the market segment. For instance, as per the Statistics Canada 2021 census, there were around 7,021,430 people aged 65 years or above, out of which 3,224,680 were males and 3,796,750 were females, living in Canada in 2021. Such a rise in the geriatric and elderly population ultimately results in facial aging, leading to wrinkles, thereby boosting the demand for these devices.

Additionally, the launch of wrinkle removal devices based on advanced technology in the country is also contributing to the growth of the segment. For instance, in January 2022, Lumenis launched the Splendor X device into United Kingdom market. The device has already received a CE mark for hair removal, vascular treatments, pigmented lesions, and the treatment of wrinkles. The system is powered by BLEND X technology, which emits a binary laser at synchronized and controllable ratios of Nd: YAG (1064 nm) and Alexandrite (755 nm) wavelengths. Such launches are expected to propel the growth of the market segment. Furthermore, in April 2021, Crown Aesthetics, a division of Crown Laboratories, Inc., received United States Food and Drug Administration (FDA) clearance for SkinPen Precision for the treatment of wrinkles on the neck. Such approvals are also expected to boost the growth of the market segment.

Thus, owing to the abovementioned factors, the market segment is expected to project growth over the forecast period.

North American Region Holds the Largest Market Share of Dermatology Devices Market

North America accounted for the major share of the market studied. This trend is likely to continue due to the increasing prevalence of skin cancer and other skin diseases, such as eczema and rosacea, coupled with approval for dermatological devices and increasing awareness about aesthetic procedures.

According to the American Cancer Society's 2022 statistics, in United States, an estimated 99,780 new cases of melanoma of the skin are expected to be reported in 2022. Of those, 57,180 cases are likely to be registered among males and 42,600 in females. Thus, the rising burden of skin cancer and other skin diseases is a major contributor to the increasing demand for dermatology devices, thus boosting the growth of the market.

Moreover, several medical technology companies focus on products that deliver less expensive, quicker, and more efficient patient care. For instance, in July 2020, Lancer Skincare launched the Pro Polish Microdermabrasion Device. Pro Polish enhances the efficacy of the Lancer routine by delivering surface-layer microdermabrasion in a patented, handheld device. These advancements in dermatology devices, in terms of features and wide-scale application for skin diseases, are expected to bolster the demand for dermatology devices in the region. Additionally, in June 2020, AbbVie Inc. (Allergan Aesthetics) received United States Food and Drug Administration approval for JUVEDERM VOLUMA XC for the augmentation of the chin region to improve the chin profile in adults over the age of 21. Such approvals are also boosting the growth of the market.

Thus, owing to the abovementioned factors, the studied market is expected to project considerable growth over the forecast period in North America.

Competitive Landscape

The dermatology devices market is moderately competitive. The market players are expanding the dermatology devices portfolio by improving their existing product portfolios with continuous innovation in the devices that are already available in the market. The players are also adopting growth strategies to expand their product offerings, strengthen their geographical reach, and increase their customer base. Some of the major players include Cutera Inc., Hologic Inc. (Cynosure Inc.), Lumenis Ltd., Alma Lasers, Candela Corporation, and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidences of Skin Disorders
    • 4.2.2 Technological Advancements in Skin Care Devices
    • 4.2.3 Increasing Awareness on Aesthetic Procedures
  • 4.3 Market Restraints
    • 4.3.1 Side Effects Related To Dermatological Treatments
    • 4.3.2 Stringent Regulatory Policies for Medical Devices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Diagnostic Devices Type
    • 5.1.1 Imaging Devices
    • 5.1.2 Dermatoscopes
    • 5.1.3 Microscopes
  • 5.2 By Diagnostic Devices Application
    • 5.2.1 Skin Cancer Diagnosis
    • 5.2.2 Other Diagnostic Device Applications
  • 5.3 By Treatment Devices Type
    • 5.3.1 Light Therapy Devices
    • 5.3.2 Lasers
    • 5.3.3 Electrosurgical Equipment
    • 5.3.4 Liposuction Devices
    • 5.3.5 Microdermabrasion Devices
    • 5.3.6 Cryotherapy Devices
  • 5.4 By Treatment Devices Application
    • 5.4.1 Vascular Lesions
    • 5.4.2 Acne, Psoriasis, and Tattoo Removal
    • 5.4.3 Hair Removal
    • 5.4.4 Wrinkle Removal
    • 5.4.5 Body Contouring and Fat Removal
    • 5.4.6 Other Treatment Device Applications
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia Pacific
    • 5.5.4 Middle East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbvie Inc. (Allergan Inc.)
    • 6.1.2 Alma Lasers Ltd
    • 6.1.3 Bausch Health Companies Inc. (Solta Medical Inc.)
    • 6.1.4 Bruker Corporation
    • 6.1.5 CANDELA CORPORATION
    • 6.1.6 Carl Zeiss
    • 6.1.7 Cutera Inc.
    • 6.1.8 Galderma SA
    • 6.1.9 Genesis Biosystems Inc.
    • 6.1.10 Hologic Inc. (Cynosure Inc.)
    • 6.1.11 Lumenis Ltd
    • 6.1.12 Merz Pharma GmbH & Co. KGaA

7 MARKET OPPORTUNITIES AND FUTURE TRENDS